Handelsbanken Fonder Ab Abb Vie Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Abb Vie Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 1,145,941 shares of ABBV stock, worth $208 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

1,145,941

Previous 1,129,124 1.49%

Holding current value

$208 Million

Previous $194 Million 16.85%

% of portfolio

0.9%

Previous 0.84%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$163.84 - $199.33 $2.76 Million - $3.35 Million	16,817 Added 1.49%	1,145,941 $226 Million
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $7.78 Million - $9.09 Million	-50,261 Reduced 4.26%	1,129,124 $194 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $900,266 - $1.03 Million	5,633 Added 0.48%	1,179,385 $215 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $7.14 Million - $8.04 Million	-51,912 Reduced 4.24%	1,173,752 $182 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $13.6 Million - $15.8 Million	-102,124 Reduced 7.69%	1,225,664 $183 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $5.83 Million - $7.25 Million	-43,965 Reduced 3.21%	1,327,788 $179 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $3.93 Million - $4.53 Million	-27,200 Reduced 1.94%	1,371,753 $219 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $1.69 Million - $2.03 Million	-12,223 Reduced 0.87%	1,398,953 $226 Million
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $4.16 Million - $4.78 Million	31,027 Added 2.25%	1,411,176 $189 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $15.2 Million - $19.3 Million	110,261 Added 8.68%	1,380,149 $211 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $14.3 Million - $17.7 Million	-107,985 Reduced 7.84%	1,269,888 $206 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $375,467 - $475,075	-3,495 Reduced 0.25%	1,377,873 $187 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $1.3 Million - $1.48 Million	12,219 Added 0.89%	1,381,368 $149 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $3.19 Million - $3.55 Million	-30,287 Reduced 2.16%	1,369,149 $154 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $3.11 Million - $3.42 Million	30,365 Added 2.22%	1,399,436 $151 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $5.91 Million - $7.98 Million	73,410 Added 5.67%	1,369,071 $147 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $6.45 Million - $7.57 Million	75,120 Added 6.15%	1,295,661 $113 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $32.8 Million - $43.9 Million	446,641 Added 57.71%	1,220,541 $120 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $8.49 Million - $12.9 Million	131,695 Added 20.51%	773,900 $59 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $158,686 - $198,550	2,200 Added 0.34%	642,205 $56.9 Million
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $9.98 Million - $12 Million	158,505 Added 32.92%	640,005 $48.5 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $25 Million - $31.9 Million	380,000 Added 374.38%	481,500 $35 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $35.5 Million - $41.8 Million	-460,826 Reduced 81.95%	101,500 $8.18 Million
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $2.88 Million - $3.55 Million	36,985 Added 7.04%	562,326 $51.8 Million
Q3 2018 Oct 19, 2018	SELL	$88.91 - $98.84 $6.18 Million - $6.87 Million	-69,500 Reduced 11.68%	525,341 $49.7 Million
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $10.8 Million - $12.7 Million	-120,000 Reduced 16.79%	594,841 $55.1 Million
Q1 2018 May 18, 2018	BUY	$92.01 - $123.21 $644,070 - $862,470	7,000 Added 0.99%	714,841 $67.7 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $3.67 Million - $4.03 Million	-41,000 Reduced 5.48%	707,841 $68.5 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $52.3 Million - $66.8 Million	748,841	748,841 $66.5 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Abb Vie Inc. Transaction History